|Bid||0.0890 x N/A|
|Ask||0.1700 x N/A|
|Day's range||0.1260 - 0.1300|
|52-week range||0.1220 - 0.3720|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Step into the foyer of the Whitechapel Hotel in the East End of London and it seems no different from any other business in the capital.
Open Orphan Executive Chairman Cathal Friel joins Yahoo Finance Live to discuss how his company is testing vaccines through intentional infection.